Covid-19 roundup: Cancer biotech to submit EUA for Covid drug; FDA OKs Eli Lilly JAK inhibitor
As vaccine talk wanes, re-purposed treatments take center stage for Covid-19.
Veru, which started out as a cancer outfit, plans to request an EUA for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
